Transauricular Neurostimulation for Abdominal Pain Due to DGBI
NCT: NCT07798180 · RECRUITING
Brief Summary
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.
Frequently Asked Questions
What is Transauricular Neurostimulation for Abdominal Pain Due to DGBI?
Transauricular Neurostimulation for Abdominal Pain Due to DGBI is a clinical trial registered under NCT07798180. Current status: RECRUITING.
What is the status of NCT07798180?
The current status of NCT07798180 (Transauricular Neurostimulation for Abdominal Pain Due to DGBI) is: RECRUITING.
When did Transauricular Neurostimulation for Abdominal Pain Due to DGBI start?
Transauricular Neurostimulation for Abdominal Pain Due to DGBI started on 2025-10-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.